1.5 Abstract in rivista
 Distribuzione geografica
Continente #
AS - Asia 15.216
NA - Nord America 3.262
EU - Europa 1.683
SA - Sud America 86
AF - Africa 70
OC - Oceania 68
Totale 20.385
Nazione #
SG - Singapore 11.889
US - Stati Uniti d'America 3.087
CN - Cina 1.600
HK - Hong Kong 1.242
GB - Regno Unito 552
IT - Italia 416
DE - Germania 218
IN - India 208
CA - Canada 127
NL - Olanda 89
AU - Australia 59
BR - Brasile 57
EE - Estonia 54
FI - Finlandia 54
CZ - Repubblica Ceca 52
TR - Turchia 48
MX - Messico 42
PL - Polonia 39
FR - Francia 38
JP - Giappone 37
UA - Ucraina 31
ES - Italia 26
ID - Indonesia 26
PK - Pakistan 26
ZA - Sudafrica 25
AE - Emirati Arabi Uniti 17
EG - Egitto 15
SE - Svezia 15
TW - Taiwan 15
AR - Argentina 13
AT - Austria 12
BD - Bangladesh 11
PH - Filippine 11
SA - Arabia Saudita 11
VN - Vietnam 11
IE - Irlanda 10
MY - Malesia 10
DK - Danimarca 9
CH - Svizzera 8
ET - Etiopia 8
LT - Lituania 8
RU - Federazione Russa 8
CL - Cile 7
IL - Israele 7
TH - Thailandia 7
KR - Corea 6
NG - Nigeria 6
PT - Portogallo 6
NO - Norvegia 5
NP - Nepal 5
NZ - Nuova Zelanda 5
RO - Romania 5
SK - Slovacchia (Repubblica Slovacca) 5
GH - Ghana 4
HU - Ungheria 4
KZ - Kazakistan 4
SI - Slovenia 4
CO - Colombia 3
EC - Ecuador 3
GR - Grecia 3
IR - Iran 3
KW - Kuwait 3
LK - Sri Lanka 3
AZ - Azerbaigian 2
BE - Belgio 2
CU - Cuba 2
IQ - Iraq 2
JM - Giamaica 2
LV - Lettonia 2
MA - Marocco 2
MK - Macedonia 2
OM - Oman 2
PG - Papua Nuova Guinea 2
PS - Palestinian Territory 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BW - Botswana 1
CD - Congo 1
CG - Congo 1
GD - Grenada 1
GE - Georgia 1
GN - Guinea 1
HR - Croazia 1
IS - Islanda 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MS - Montserrat 1
NA - Namibia 1
PE - Perù 1
PY - Paraguay 1
RE - Reunion 1
RS - Serbia 1
Totale 20.380
Città #
Hong Kong 1.220
Singapore 1.027
Hefei 988
Ashburn 787
Boardman 580
London 457
Shanghai 342
Dallas 330
Beijing 210
Los Angeles 146
Council Bluffs 138
San Francisco 119
Pune 110
Rome 98
West Jordan 90
Munich 70
Amsterdam 63
Washington 60
Toronto 55
Seattle 46
Santa Clara 44
Brno 40
Milan 39
Sona 36
Chicago 35
Brooklyn 34
Warsaw 34
Turku 33
New York 32
Mexico City 30
Montreal 24
São Paulo 23
Tokyo 23
Helsinki 21
Canberra 18
Chennai 18
Hanover 18
Melbourne 18
Boston 16
Paris 15
Central 13
Johannesburg 13
Charlotte 12
Manchester 12
Naples 12
Stockholm 12
Riyadh 11
Sydney 11
Glasgow 10
New Delhi 10
Olomouc 10
Secaucus 10
Atlanta 9
Berlin 9
Phoenix 9
Andover 8
Ankara 8
Buffalo 8
Copenhagen 8
Istanbul 8
San Jose 8
Bangkok 7
Brescia 7
Dublin 7
Manila 7
Nuremberg 7
Oklahoma City 7
Redmond 7
Vienna 7
Addis Ababa 6
Arlington 6
Bologna 6
Cairo 6
Jakarta 6
Kuala Lumpur 6
Pittsburgh 6
Swat 6
Vancouver 6
Auckland 5
Beitou 5
Bengaluru 5
Bergen 5
Bratislava 5
Calgary 5
Catania 5
Dubai 5
Gazoldo degli Ippoliti 5
Kolkata 5
Perth 5
Rawalpindi 5
San Diego 5
Sittard 5
Tallinn 5
Budapest 4
Florence 4
Genoa 4
Helena 4
Kansas City 4
Kathmandu 4
Markham 4
Totale 7.911
Nome #
PLASTIC IN PLACENTA: WHAT IS IT? WHAT TO DO? 258
18F-Choline PET/CT for early detection of prostate cancer recurrence after radical prostatectomy 251
1338P TP53 truncating and missense mutations are linked to differential response to checkpoint blockade in patients with advanced non-small cell lung cancer (NSCLC) 230
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 225
112P Measuring time-toxicity and prognostic impact of hospital attendance in early phase cancer trials participants 218
Effect of hypothermia on human colonic smooth muscle contractility 208
1065P Dose dependent detrimental effect of baseline pantoprazole on clinical outcomes from first-line chemo-ICI regimens in patients with advanced stage NSCLC 207
A new adjunct for emergency airway management:the Laryngeal Tube, preliminary data 205
Abstract 486: MicroRNA-30 family members inhibit breast cancer invasion, osteomimicry, and bone destruction by directly targeting multiple bone metastasis-associated genes 205
Purse-String Closure vs Conventional Direct Closure of Wounds after Stoma Reversal: A Prospective Randomized Controlled Study 201
1352P Real-world second-line outcomes of NSCLC patients receiving first-line chemotherapy plus immunotherapy 199
69P Dose-dependent detrimental effect of proton pump inhibitors (PPIs) on clinical outcomes from immune checkpoint inhibitors (ICI) in patients (pts) with solid tumors 199
96P Induction chemotherapy backbone in frail patients (pts) with advanced NSCLC treated with chemotherapy plus pembrolizumab (P): A single institution retrospective audit of dose intensities from modified regimens 197
A biomechanical index for the evaluation of upper arm motor control in a subject affected by polyradiculoneuropathy 195
P3.13C.09 First-Line Treatments for Advanced Pure Large Cell Neuroendocrine Tumors (LCNEC):Insights from a Global Clinico-Genomic Study 190
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 189
602 Frequent Epigenetic Inactivation of KEAP1 Gene in Breast Cancer 188
Disclosing 3D Shape of Ossa Genitalia in Primates 187
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 186
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 186
METAL HOMEOSTASIS IN PATIENTS WITH PORTO-SYSTEMIC ENCEPHALOPATHY 185
Postoperative Serum Procalcitonin to Predict Clinically Relevant Pancreatic Fistula after Pancreatoduodenectomy 184
Does HE4 have a role in the recurrence of ovarian cancer? 183
Chronotherapy and surgery for unresectable hepatic metastases from colorectal cancer 181
Early opioid exposure (EOE) and impaired efficacy in patients with advanced NSCLC treated with PD-L1 inhibition: A pooled post hoc analysis of the POPLAR and OAK trials 180
AB0550 PHENOTYPE OF BIOPSY-PROVEN PATIENTS WITH PRIMARY SJÖGREN SYNDROME LACKING RO AUTOANTIBODIES: HIGH FREQUENCY OF DRYNESS SYMPTOMS WITH LOW SYSTEMIC ACTIVITY (BIG DATA SJÖGREN PROJECT) 180
BREATH PRINT ANALYSIS BY E-NOSE IS ASSOCIATED WITH ADVERSE OUTCOMES OF CIRRHOTIC PATIENTS INDEPENDENTLY FROM THE OTHER PROGNOSTIC INDICES 179
Risultati preliminari dell’uso della risonanza magnetica nello studio dei disturbi dell’evacuazione 179
Aligned electrospun poly-l-lactide fibers for tendon regeneration: a preliminary in vitro study 177
Diagnosis of labour: the II prospective clinical study 176
APPLICATION OF RADIOFREQUENCY INTERSTITIAL TUMOR ABLATION(RITA) IN "NO CLAMP-NO SUTURE" LAPAROSCOPIC PARTIAL NEPHRECTOMY 176
Gait Speed Is a Valid Indicator in the Assessment of Perioperative Risk in the Elderly Surgical Patient 176
3D Bioprinting of Human Skin and Squamous Cell Tumors (SCCs) as Advanced Models for Precision Medicine (BIOSQIN) 172
EP24.13: Fetomaternal hemorrhage: a new hypothesis on the importance of fetal vasoconstriction – a case report 170
1-year results of the subclavian access for tavi with the corevalve bioprosthesis in 132 consecutive patients 170
Assessment of liver function by the exhaled breath-print during chronic liver disease 169
CARBOPLATINUM IN NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED CERVICAL CANCER: A PILOT STUDY. 165
Biomimetic Polyurethane Scaffolds Guiding the In Vitro Behavior of Cardiac Stem Cells 164
Hepatic Artery Anomaly Does Not Impact Pancreatoduodenectomy Outcomes: A Matched Pair Analysis 161
Aberrant expression of IL-22RA1 on hematopoietic cells as immunologically signature of primary sjogren’s syndrome and sjogren-associated non-hodgkin lymphomas 159
AB0458 A PHASE II RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PROOF OF CONCEPT STUDY OF ORAL SELETALISIB IN PATIENTS WITH PRIMARY SJÖGREN’S SYNDROME (PSS) 156
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY 144
The Hendrich II model for assessing the risk of falls for hospitalized patients [Il modello Hendrich II per la valutazione del rischio di cadute per pazienti ospedalizzati] 140
THU-390 - Hepatic expression of lysosomal acid lipase is reduced in non-alcoholic fatty liver disease and inversely associated with the degree of microvescicular steatosis, impairment of the autophagic process and NAFLD activity score 129
18F-CHOLINE PET/CT FOR EARLY DETECTION OF PROSTATE CANCER RECURRENCE AFTER RADICAL PROSTATECTOMY. 122
Cerebral Hemodynamics, Patent foramen ovale and White Matter Hyperintensities in patients Migraine with aura, young stroke patients and controls 119
Abruptio placenta and TLRs 2-3-4 116
35. Association of robot-assisted rehabilitation and non-invasive brain stimulation to improve upper limb function in chronic stroke patients 107
Prospective observational multicentric case-control study about 'fatigue' in patients with history of breast cancer 106
GH-resistance in different stages of chronic liver disease 104
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 103
534 Determinants of 5-year survival in patients with advanced NSCLC with PD-L1 ≥50% treated with first line pembrolizumab outside of clinical trials: results from the Pembro-real 5Y global registry 102
A case of synchronous hepatic and gastric malignancies: diagnostic problems and therapeutical strategies 102
A polysaccharide foam-like scaffold obtained by crosslinking lactose-modified chitosan and oxidized hyaluronan 100
The ability of Lung High-Resolution Computed Tomography Severity Score to early identify COVID-19 patients who need respiratory support. A retrospective analysis of a monocentric Italian COVID-19 cohort 98
485 Impact of opioid signaling on the tumor microenvironment and clinical outcomes in patients with non-small cell lung cancer (NSCLC) treated with immune checkpoint inhibitors (ICIs) 97
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 94
EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm 92
"NO CLAMP NO SUTURE'' LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR SMALL EXOPHYTIC RENAL TUMORS 92
Assessment of renal damage following warm ischemia time during LPN: results of a prospective study 91
Chemokines and Inflammatory Mediators in Erosive Esophagitis (EE) Compared to Non-Erosive Reflux Disease (NERD) and Control Patients 91
Afatinib, an irreversible ErbB family inhibitor, demonstrates activity against HER2 mutated cervical cancer in vitro 91
Abstract P5-04-13: Antibody-based therapy targeting integrin a5 is an effective strategy to treat experimental breast cancer bone metastasis 91
Amniotic membrane transplantation associated with conjunctival peritomy in the management of Mooren's ulcer. 90
Baccalaureate nursing students’ attitudes towards old people 90
Biological effects of cabozantinib on bone microenvironment 90
A meta-synthesis of experiences of caregivers of people with COPD. 89
A randomized phase II study assessing an optimized schedule of oregovomab (0) anti-CA1 25 vaccination with carboplatin paclitaxel (CP) relative to CP alone in front-line treatment of optimally cytoreduced stage III/IV ovarian cancer (EOC) 89
Body Mass Index and Impaired Fasting Blood Glucose as Predictive Factors of Efficacy in Cetuximab-Based Colorectal Cancer Treatment 89
Biological effects of cabozantinib on osteosarcoma-bone microenvironment model 89
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 88
A Systematic Review of the Role of Lymphadenectomy in Pancreatic Cancer 88
Alimentazione e gravidanza fisiologica 88
Different Levels of Alkaline Phospatase (ALP) in Multiple Myeloma (MM) and SOLID Tumors with BONE Lesions 88
THU-464 aMAP score predicts progression-free survival in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma 88
A New Technique for Laparoscopic Stripping of Endometriomas: FloSeal Hemostatic Agent for Hemostasis of the Ovarian Wall 87
OS-078-YI Hepatic decompensation as an aetiology-dependent determinant of mortality in patients with hepatocellular carcinoma treated with atezolizumab plus bevacizumab 86
Long non-coding RNA HSAT II as a new biomarker for the identification of high risk intraductal papillary mucinous neoplasms (IPMNs). 86
Integrated treatment of pancreatic head carcinoma 85
35 DNA DOUBLE STRANDS BREAK REPAIR GENES EXPRESSION ANALYSIS REVEAL RAD51 AS A NEW POTENTIAL BIOMARKER IN BREAST CANCER. 85
Amniotic membrane produces and releases nerve growth factor (NGF) and expresses NGF receptors 84
). IL-6 e TGF-b1 nel siero e nei sovranatanti di cellule mononucleate in pazienti con sclerosi sistemica (SSC). 84
706. DNA Vaccine Strategy Against Chronic B-Cell Lymphoma: Anti-Idiotypic CDR3 Vaccination 84
METAL METABOLISM IMPAIRMENT IN PATIENTS WITH HEPATIC ENCEPHALOPATHY 84
ALT levels are associated with metabolic parameters and age in a large real-life population. 84
66 ABERRANT GENES PROMOTER METHYLATION IN NEURAL-CREST DERIVED TUMOURS 84
45 GENE EXPRESSION OF SOMATOSTATIN RECEPTOR SUBTYPES SSTR2a, SSTR3 AND SSTR5 IN PERIPHERAL BLOOD OF NEUROENDOCRINE LUNG CANCER AFFECTED PATIENTS 83
5-YEAR ONCOLOGIC OUTCOMES FOR ROBOT-ASSISTED AND LAPAROSCOPIC PARTIAL NEPHRECTOMY FOR HIGH-RISK RENAL TUMORS 83
Continent ileocolonic urinary diversion (rome pouch) for gynecologic malignancies: techniqueand feasibility. 82
Clinical outcomes and post-progression retreatment in patients with metastatic NSCLC who complete two years of treatment with immune checkpoint blockade 80
ECONOMIC IMPACT AMONG FAMILY CAREGIVERS OF ADVANCED OVARIAN CANCER PATIENTS 79
Combined multimodality treatment of primary or recurrent locally advanced rectal cancer 79
"NO CLAMPING-NO SUTURING" LAPAROSCOPIC PARTIAL NEPHRECTOMY (LPN). 78
EVIDENCE FOR REDUCED ANGIOGENESIS IN BONE MARROW (BM) IN SYSTEMIC SCLEROSIS (SSC) 76
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with Sjogren’s syndrome 75
Adjuvant external and intraoperative radiation therapy in resectable pancreatic cancer 75
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 73
T.07.3: CHARACTERISTICS AND OUTCOMES OF IMMUNOTHERAPYRELATED LIVER INJURY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA COMPARED TO PATIENTS WITH ADVANCED SOLID TUMOURS 71
Drug releasing hybrid scaffold: new avenue in cardiovascular tissue engineering 68
How long is the latent phase of labour? 63
Totale 13.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022708 0 0 11 6 57 8 6 3 24 32 13 548
2022/2023387 29 11 8 32 43 26 33 22 24 35 108 16
2023/20241.852 82 163 76 113 203 821 33 84 22 135 35 85
2024/202515.422 230 198 622 65 107 342 219 69 1.263 1.172 5.232 5.903
2025/20262.124 1.370 507 247 0 0 0 0 0 0 0 0 0
Totale 20.493